Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations (SURF301)
NCT 05544552 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 05544552 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 04450732 Brief Summary Phase I Dose Finding Study for GQ1001 in…
Read more arrow_forwardNCT 06712316 Brief Summary This is a Phase 2/3, multisite, randomized, open-label…
Read more arrow_forwardNCT 05261399 Brief Summary Clinical study to investigate the efficacy and…
Read more arrow_forwardNCT 05480865 Brief Summary This is a Phase 1 study of BBP-398,…
Read more arrow_forwardNCT 06736704 Brief Summary This study is testing a new medicine, SNV4818,…
Read more arrow_forwardNCT 05614258 Brief Summary ADG206 is an activatable prodrug form of a…
Read more arrow_forwardNCT 05910827 Brief Summary This is a phase 1b multi-center, open-label…
Read more arrow_forwardNCT 05919537 Brief Summary This is a phase 1b multi-center, open-label study…
Read more arrow_forwardNCT 05267626 Brief Summary This is a first in human, open-label, multi-center…
Read more arrow_forward